Skip to content
Vital Therapies logo

Vital Therapies Alternatives & Competitors

12 companies similar to Vital Therapies — Pioneering the future of liver therapy with innovative cell-based treatments for...

Companies similar to Vital Therapies

Hexaell Biotech logo — alternative to Vital Therapies

Hexaell Biotech

Pioneering the future of stem cell and artificial organ technology with breakthrough solut...

Targazyme logo — alternative to Vital Therapies
Celularity Inc. logo — alternative to Vital Therapies

Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...

Brainstorm Cell Therapeutics logo — alternative to Vital Therapies

Rival Readout

Competing with Vital Therapies? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Cognate BioServices, a Charles River Company logo — alternative to Vital Therapies

Cognate BioServices, a Charles River Company

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Angiocrine Bioscience, Inc. logo — alternative to Vital Therapies

Angiocrine Bioscience, Inc.

Transforming medicine through engineered cellular therapies that restore, regenerate, and...

Rebirthel Co.,Ltd. logo — alternative to Vital Therapies

Rebirthel Co.,Ltd.

An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.

CUTISS AG logo — alternative to Vital Therapies

CUTISS AG

FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company

Arcellx logo — alternative to Vital Therapies

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

Metcela Inc. logo — alternative to Vital Therapies

Metcela Inc.

Unleash the Cell Potential.

TC BioPharm  logo — alternative to Vital Therapies

TC BioPharm

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

ImmuneBridge logo — alternative to Vital Therapies

ImmuneBridge

Bridging research and translation for a healthy future.

About Vital Therapies

Vital Therapies is a biotechnology and healthcare startup that has been making waves in the field of liver therapy. The company's flagship product, the ELAD System, is a pioneering cell-based therapy designed to address acute liver failure. This innovative extracorporeal bio-artificial liver therapy, containing human l...

Business keywords

Cell-based Therapy, Acute Liver Failure, ELAD System, Bio-artificial Liver Therapy, Phase III Clinical Trials, Vital Therapies, C3A Cells, Clinical Studies, Orphan Designation, Allogeneic Cellular Therapy, Compassionate Use Program, Regenerative Medicine, Liver Treatment

Frequently Asked Questions

Companies similar to Vital Therapies include Hexaell Biotech, Targazyme, Celularity Inc., Brainstorm Cell Therapeutics, Cognate BioServices, a Charles River Company. They work in Biotechnology and Health Care and share Vital Therapies's focus on regenerative medicine and cell-based therapy.
Bounce Watch lists 12 companies that share Vital Therapies's industries and are closest to it in business tags, services, target customers, business model and size.
Vital Therapies is a biotechnology and healthcare startup that has been making waves in the field of liver therapy. The company's flagship product, the ELAD System, is a pioneering cell-based therapy designed to address acute liver failure. This innovative extracorporeal bio-artificial liver therapy, containing human l...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Vital Therapies: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Vital Therapies on 21 Jun 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout